Common variants in the GLP-1 receptor are associated with glycaemic response to GLP-1 receptor agonists in observational and large RCT data: an IMI-DIRECT study

被引：0
|
作者：
Dawed, A. Y. [1 ]
Mari, A. [2 ]
McDonald, T. J. [3 ,4 ]
Robertson, N. R. [5 ]
Mahajan, A. [6 ]
Walker, M. [7 ]
Gough, S. [8 ]
Zhou, K. [1 ]
Forgie, I. [1 ]
Ruetten, H. [9 ]
Pavo, I. [10 ]
Pillai, S. G. [10 ]
Jones, A. G. [3 ,4 ]
Pearson, E. R. [1 ]
机构：
[1] Univ Dundee, Mol & Clin Med, Dundee, Scotland
[2] CNR, Inst Neurosci, Padua, Italy
[3] Univ Exeter, NIHR Exeter Clin Res Facil, Exeter, Devon, England
[4] Royal Devon & Exeter Hosp, Exeter, Devon, England
[5] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Clin Med, Oxford, England
[6] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England
[7] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[8] NIHR Oxford Biomed Res Ctr, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[9] Sanofi Aventis Deutsch GmbH, TMED, Frankfurt, Germany
[10] Eli Lilly Res Labs, Indianapolis, IN USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
39
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [32] Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
    Janic, Miodrag
    Skrgat, Sabina
    Harlander, Matevz
    Lunder, Mojca
    Janez, Andrej
    Pantea Stoian, Anca
    El-Tanani, Mohamed
    Maggio, Viviana
    Rizzo, Manfredi
    MEDICINA-LITHUANIA, 2024, 60 (12):
  • [33] The Effect of GLP-1 Receptor Agonists on Bowel Preparation
    Mahmood, Sabah
    Ozminkowski, Erin
    Sakiri, Ahmet
    Aqeel, Ammar
    Abbasi, Abu Fahad
    Andersen, William
    Zhan, Weihai
    Khan, Naser
    Hamoudah, Thayer
    Dawood, Altaf
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S360 - S361
  • [34] GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation
    Madsen, Lars Wichmann
    Knauf, Jeffrey A.
    Gotfredsen, Carsten
    Pilling, Andrew
    Sjogren, Ingrid
    Andersen, Soren
    Andersen, Lene
    de Boer, Anne Sietske
    Manova, Katia
    Barlas, Afsar
    Vundavalli, Sushil
    Nyborg, Niels C. Berg
    Knudsen, Lotte Bjerre
    Moelck, Anne Marie
    Fagin, James A.
    ENDOCRINOLOGY, 2012, 153 (03) : 1538 - 1547
  • [35] GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    Bezin, Julien
    Gouverneur, Amandine
    Penichon, Marine
    Mathieu, Clement
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    DIABETES CARE, 2023, 46 (02) : 384 - 390
  • [36] Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
    Alhiary, Rasha
    Kesselheim, Aaron S.
    Gabriele, Sarah
    Beall, Reed F.
    Tu, S. Sean
    Feldman, William B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 650 - 657
  • [37] Mapping the effectiveness and risks of GLP-1 receptor agonists
    Xie, Yan
    Choi, Taeyoung
    Al-Aly, Ziyad
    NATURE MEDICINE, 2025, : 1038 - 1038
  • [38] Why are GLP-1 receptor agonists in short supply?
    Bailey, Clifford J.
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 72 - 72
  • [39] GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
    Suissa, Karine
    Cromer, Sara J.
    Patorno, Elisabetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10):
  • [40] GLP-1 receptor agonists and the risk of colorectal cancer
    Kakkar, Ashish Kumar
    MEDICAL HYPOTHESES, 2014, 82 (06) : 796 - 796
12345